Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4730294

CNC1CCC(NCc2cc(-c3ccc(Cl)cc3)ccc2F)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.39
PRCP P42785 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
GPR6 P46095 2/20 0.36
ACLY P53396 1/20 0.36
CHRM4 P08173 1/20 0.36
PARP1 P09874 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
BACE1 P56817 1/20 0.35
SHMT1 P34896 1/20 0.35
SHMT2 P34897 1/20 0.35
CXCR3 P49682 1/20 0.35
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
DPP7 Q9UHL4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4728849 0.92 MEN1 (0.42) GPR6ACLYPARP1BACE1
Trifluoroacetic Acid SCHEMBL4731677 0.91 PARP1 (0.36) GPR6CHRM4PARP1ADRB3DPP4
Trifluoroacetic Acid SCHEMBL4731470 0.90 TRPA1 (0.42) MCHR1POLBADRB1ADRB3DPP4
Trifluoroacetic Acid SCHEMBL4735931 0.89 HDAC1 (0.37) MCHR1GPR6PARP1BACE1DPP4
Trifluoroacetic Acid SCHEMBL4734028 0.89 KIF11 (0.42) MCHR1GPR6PARP1DPP4DPP8
Trifluoroacetic Acid SCHEMBL4735936 0.89 CNR1 (0.41)
Trifluoroacetic Acid SCHEMBL4730291 0.88 POLB (0.43) MCHR1HTR2CHTR2BPOLBF2
Trifluoroacetic Acid SCHEMBL4734021 0.88 HTT (0.38) MCHR1HTTDPP4DPP8DPP7
Trifluoroacetic Acid SCHEMBL4733338 0.88 GPR6 (0.40) MCHR1GPR6ADRB3
Trifluoroacetic Acid SCHEMBL4734148 0.87 FFAR1 (0.35) MCHR1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273747-B2 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin CURIS, INC. (US) 2012-09-25 US disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080194637-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin CURIS, INC. (US) 2008-07-31 US disclosed
WO-2008057497-A2 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057468-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO MCHR1 1785/4885PRCP 4053/4885HTR2C 3018/4885
US-20080194637-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO MCHR1 1785/4885PRCP 4053/4885HTR2C 3018/4885
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin SHH, GLI1, SMO MCHR1 273/4885PRCP 3074/4885HTR2C 1714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.